The global hereditary testing market size was valued at USD 6 billion in 2020 and is projected to register at a CAGR of 6.4% and expected to reach at USD 10.50 billion in 2029 during the forecast period 2022 to 2029.

Get Sample Pages PDF (Including Full TOC, Table & Figures)

https://exactitudeconsultancy.....com/reports/3449/her

Competitors in Hereditary Testing Market Report Are Agilent Technologies, Inc., Centogene N.V., CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Medgenome, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, Sophia Genetics, Thermo Fisher Scientific, Inc, and Twist Bioscien, and others.